RSV
-
Companies
Moderna RSV vaccine trial paused after five infants required hospitalization
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…
Read More » -
Discoveries & Research
Researchers use biophysics to design new vaccines against RSV and related respiratory viruses
In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms.…
Read More » -
Discoveries & Research
Study reveals best timing for getting the RSV vaccine during pregnancy to protect newborns
Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) — which typically causes mild, cold-like…
Read More » -
Discoveries & Research
RSV vaccines effective, but more people need to get them
Since their introduction last year, researchers have been monitoring the real-world impact of the new respiratory syncytial virus (RSV) vaccines.…
Read More » -
Discoveries & Research
Researchers identify signs tied to more severe cases of RSV
Respiratory syncytial virus (RSV) is the leading cause of hospitalization in young children due to respiratory complications such as bronchiolitis…
Read More » -
Technology
Making an RSV Vaccine Was Hard. Getting People to Take It Is Even Harder
Carina Marquez, an associate professor of medicine at the University of California, San Francisco, is a big believer in prevention.…
Read More » -
Discoveries & Research
New images of RSV may expose stubborn virus’s weak points
The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments for an infection that leads…
Read More » -
Technology
RSV Can Be a Killer. New Tools Are Identifying the Most At-Risk Kids
After 25 years as a pediatric infectious diseases specialist, Asunción Mejías is too familiar with the deadly unpredictability of respiratory…
Read More » -
Politics
Canada approved multiple RSV shots to ward off infections this fall — here’s how to get them
Respiratory syncytial virus, or RSV, isn’t always top of mind during the colder months. It’s often overshadowed by flu season,…
Read More » -
Discoveries & Research
New RSV vaccine for older adults can result in individual and societal cost savings, benefits
Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life…
Read More »
